• news-banner

    Expert Insights

COVID-19: Advertising Responsibly

min read

The ASA continues its drive to ensure responsible advertising during the COVID-19 pandemic.

At the outset of the pandemic the ASA took swift action to highlight to advertisers it would act quickly and robustly against ads that exploited people’s health related anxieties and the difficult financial or employment circumstances many people were facing. The ASA also published guidance on the main areas in which it believed ads may be deemed problematic. Despite this there have been a number of ads which have fallen foul of the CAP Code.

The latest series of problematic ads related to a vitamin C drink containing claims such as “Vitamin-C has been proven to boost immunity” which, taken in the midst of the pandemic, could be taken to imply that the drink could help to prevent, treat or cure COVID-19. Making such claims is not permitted unless the products in question are authorised on the EU Register of nutrition and health claims, which this product was not. It is also prohibited to make claims that food and supplements can prevent, treat or cure human disease. The ASA therefore held that the ads must not appear again.

Below we have outlined the ASA guidance and rulings since the beginning of the pandemic to highlight the main areas of concern which may have the potential to grossly undermine the UK’s response to the pandemic.

Key Areas of concern and ASA Rulings

1. Medicines and medical devices:

The key issue in this space is that ‘medical or medicinal claims’ can only be made for products where they are licenced medicines or appropriately marked medical devices.

ASA Rulings:

  • The ASA banned an ad which promoted an “Anti-Corona Virus Face Mask”.
  • The ASA banned a series of ads which promoted a “New Nano Tech Face Mask” and implied that the mask would offer protection against being infected by COVID-19.

2. Alternative and complementary therapies

The ASA made clear that it was likely to consider COVID-19 a condition for which medical supervision should be sought.

ASA Rulings:

  • The ASA banned advertising claims on websites and in social media made by three clinics offering IV drip treatments which made medicinal claims that implied they could prevent or treat COVID-19.

3. Food or food supplements

As seen above, the ASA made clear that ads that make health related claims and/or suggest a product may help protect consumers from infection of COIVD-19 by, for example, supporting their immune system, were likely to be viewed as problematic.

4. Fear, distress and social responsibility

The ASA highlighted that ads should not exploit an audience’s fear in order to mislead them into buying a product.

ASA Rulings:

  • The ASA banned an ad which stated “British Build, beds proudly made in the UK. No Nasty imports”. The ad also contained imagery whereby a cartoon mattress was wearing a green surgical mask. In the ASA’s view the ad was likely to cause serious or widespread offence as in combination with the image the reference to “nasty imports” was likely to be read as a negative reference to immigration or race.

Moving Forward

Ads in any of the special interest areas above will likely receive additional scrutiny from both the public and regulators. Advertisers must exercise special caution and be mindful of how ads may be perceived by the public in the current heightened state of awareness, especially if those ads contain health-related claims.
For more information on any of the ASA Rulings set out above, please use the following link

Our thinking

  • Alumni drinks reception

    Events

    min read
  • Practicalities of Property Management Seminar

    Events

    min read
  • The Next Frontier? Follow On Claims and the Future of Loss of Chance Litigation in International Sports

    Daniel McDonagh

    Events

    min read
  • SLAPPs, Scrolls & Silencing: Media Law Under the Spotlight

    Claudine Morgan

    Events

    min read
  • Bridging East and West: Resolving China Related Disputes in a Global Era

    Jue Jun Lu

    Events

    min read
  • Court Determined Global Licence Determinations (Interim and Final): Cross Border Complexities

    Robert Lundie Smith

    Events

    min read
  • Steering the Ship: Navigating the Seas of Trust Applications without Capsizing into Hostile Litigation

    Robert Avis

    Events

    min read
  • What inheriting an interest in a regulated business really means for you

    Charlie Ring

    Insights

    min read
  • To charge or not to charge? That is the question facing the UK’s National Museums

    Suzanne Marriott

    Insights

    min read
  • Switzerland plans further restrictions to buying real estate

    Oliver Schreier

    Quick Reads

    min read
  • Charles Russell Speechlys wins ‘Best Law Firm for Training’ at the Legal Cheek Awards 2026

    Karen Stages

    News

    min read
  • Building Safety in the UK: A Period of Significant Reform

    Tegan Johnson

    Insights

    min read
  • The Playbook to Superscale: Hacks 1-3

    Events

  • Navigating the Rise of AI-Generated DSARs and complaints – our top tips

    Janine Regan

    Quick Reads

    min read
  • A range of publications including Edie.net, Energy Voice and Environment Journal quote Kevin Gibbs on the Energy Independence Bill set out in the King's Speech

    Kevin Gibbs

    In the Press

    min read
  • Charles Russell Speechlys appoints First Corporate Tax Partner in Milan

    Michael Lingens

    News

    min read
  • Jonathan Burt comments in The Telegraph on HMRC’s consultation on the Uncertain Tax Treatment regime

    Jonathan Burt

    In the Press

    min read
  • Miranda Fisher and Hannah Owen write in the Daily Mail's This is Money section on whether you can divorce your parents

    Miranda Fisher

    In the Press

    min read
  • Keir Gordon and Molly Moseley write in City AM about how high-net-worth individuals can rival private equity in sport

    Keir Gordon

    In the Press

    min read
  • Charles Russell Speechlys shortlisted in two categories for Legal Business Awards 2026

    Lesley O’Leary

    News

    min read
Back to top